HIF1A and cancer: In many solid tumors, HIF-1 activation allows cancer cells to adapt to their environment via metabolic reprogramming and angiogenesis and increases the metastatic potential and resistance to chemotherapy and radiotherapy via epithelial–mesenchymal transition [29–32].